DE1767994C2 - Arzneimittel mit antacidem und absorptivem Wirkstoff - Google Patents
Arzneimittel mit antacidem und absorptivem WirkstoffInfo
- Publication number
- DE1767994C2 DE1767994C2 DE19681767994 DE1767994A DE1767994C2 DE 1767994 C2 DE1767994 C2 DE 1767994C2 DE 19681767994 DE19681767994 DE 19681767994 DE 1767994 A DE1767994 A DE 1767994A DE 1767994 C2 DE1767994 C2 DE 1767994C2
- Authority
- DE
- Germany
- Prior art keywords
- antacid
- medicines
- active ingredients
- absorptive
- precipitate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003814 drug Substances 0.000 title claims description 12
- 239000003159 antacid agent Substances 0.000 title claims description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 title claims description 6
- 229940069428 antacid Drugs 0.000 title claims description 6
- 230000001458 anti-acid effect Effects 0.000 title claims description 6
- 239000004480 active ingredient Substances 0.000 title claims description 4
- 229940079593 drug Drugs 0.000 title claims description 3
- 239000000203 mixture Substances 0.000 claims description 9
- 239000002244 precipitate Substances 0.000 claims description 6
- 239000004115 Sodium Silicate Substances 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 239000007900 aqueous suspension Substances 0.000 claims description 2
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052911 sodium silicate Inorganic materials 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims 1
- 229910052782 aluminium Inorganic materials 0.000 claims 1
- 150000002681 magnesium compounds Chemical class 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 5
- 229910004298 SiO 2 Inorganic materials 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 229910052625 palygorskite Inorganic materials 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010020601 Hyperchlorhydria Diseases 0.000 description 2
- 239000003929 acidic solution Substances 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 2
- 229960000892 attapulgite Drugs 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- -1 magnesium-aluminum silicates Chemical class 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 238000004438 BET method Methods 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940010698 activated attapulgite Drugs 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical group O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229940099273 magnesium trisilicate Drugs 0.000 description 1
- 229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
- 235000019793 magnesium trisilicate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR113782A FR6778M (en:Method) | 1967-07-10 | 1967-07-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE1767994A1 DE1767994A1 (de) | 1971-10-21 |
| DE1767994C2 true DE1767994C2 (de) | 1983-02-17 |
Family
ID=8634853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19681767994 Expired DE1767994C2 (de) | 1967-07-10 | 1968-07-10 | Arzneimittel mit antacidem und absorptivem Wirkstoff |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE716972A (en:Method) |
| DE (1) | DE1767994C2 (en:Method) |
| FR (1) | FR6778M (en:Method) |
| GB (1) | GB1241561A (en:Method) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2435442A1 (fr) * | 1978-09-07 | 1980-04-04 | Om Lab Sa | Silicate de magnesium et d'aluminium synthetique, procede de fabrication de celui-ci et compositions pharmaceutiques comprenant celui-ci |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB925001A (en) * | 1960-09-28 | 1963-05-01 | Reckitt & Sons Ltd | Pharmaceutical compositions |
-
1967
- 1967-07-10 FR FR113782A patent/FR6778M/fr not_active Expired
-
1968
- 1968-06-21 BE BE716972D patent/BE716972A/xx not_active IP Right Cessation
- 1968-07-10 GB GB32950/68A patent/GB1241561A/en not_active Expired
- 1968-07-10 DE DE19681767994 patent/DE1767994C2/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE716972A (en:Method) | 1968-12-02 |
| FR6778M (en:Method) | 1969-03-10 |
| GB1241561A (en) | 1971-08-04 |
| DE1767994A1 (de) | 1971-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2240782A1 (de) | Verfahren zur herstellung eines eisensaccharid-komplexes | |
| DE2936078C2 (de) | Synthetisches Magnesiumaluminiumsilikat und dieses enthaltendes pharmazeutisches Präparat | |
| DE1617800A1 (de) | Verfahren zur Herstellung von oral applizierbaren,silikonhaltigen antaciden Praeparaten mit schaumbrechender Wirkung | |
| DE1087126B (de) | Verfahren zur Herstellung von wasserfreiem Ferrofumarat | |
| DE3228485A1 (de) | Antacida sowie verwendung von zeolithischen molekularsieben zur herstellung von antacida und bei der bekaempfung von hyperaciditaet | |
| DE69100954T2 (de) | Lagerstabile orale Glucosaminsulfat-Dosisformen und Verfahren zu deren Herstellung. | |
| DE1767994C2 (de) | Arzneimittel mit antacidem und absorptivem Wirkstoff | |
| US2970889A (en) | Process for the manufacture of magnesium aluminosilicate for medical uses | |
| DE3019032A1 (de) | Antacider wirkstoff auf magnesium-aluminiumhydroxid-basis, verfahren zu dessen herstellung und dessen verwendung bei der bekaempfung von magenerkrankungen und der hyperaziditaet | |
| DE2304705C2 (de) | Diätetische Mineralergänzungszubereitung | |
| DE854245C (de) | Verfahren zur Herstellung von Mitteln zur Inaktivierung proteolytischer Enzyme im Verdauungstraktus | |
| DE2443492C2 (en:Method) | ||
| DE2705433A1 (de) | Anorganische ergaenzungsnahrung, verfahren zu ihrer herstellung und ihre verwendung | |
| DE3315606C2 (en:Method) | ||
| DE69100053T2 (de) | Arzneimittelzusammensetzung in stabiler wässriger Suspensionsform auf der Basis von Sucralfat und einem Antacidum sowie Verfahren zu ihrer Herstellung. | |
| AT243822B (de) | Verfahren zur Verminderung der Neigung zum Zusammenbacken von Natriumchlorid | |
| EP0136502A2 (de) | Verwendung von Eisen(II)-, Zink- und Magnesiumsalzen und ihren Mischsalzen zur Substitution von Eisen, Zink und Magnesium | |
| CH620124A5 (en) | Magnesium chloride tablets and process for their production | |
| DE956096C (de) | Verfahren zur Herstellung von aktiviertem Siliciumdioxyd | |
| DE682270C (de) | Herstellung zusammengesetzter, Titandioxyd und Calciumsulfat enthaltender Pigmente | |
| AT115388B (de) | Verfahren zur Herstellung von bei Berührung mit Wasser Schwefelwasserstoff entwickelnden Präparaten. | |
| DE386760C (de) | Verfahren zur Herstellung eines kolloidal Ioeslichen Kieselsaeuregranulats | |
| DE2635293A1 (de) | Salzgemisch, insbesondere leicht assimilierbares arzneimittelgemisch mit erhoehter loeslichkeit, enthaltend kalziumsalze und/oder magnesiumsalze | |
| DE1617726C (de) | Stabiles, enzymhaltiges, flussiges Antacidum | |
| DE1617584C3 (de) | Wismut-Aluminium-Magnesium-Silikate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |